Pre-Eclampsia Control

Home - CSF

Pre-Eclampsia Control

The Pre-eclampsia Control is intended for use with in vitro diagnostic assays for the quantitative determination of placental growth factor (PlGF) and soluble fms‑like tyrosine kinase‑1 (sFlt-1) in human serum and plasma.
The Pre-eclampsia Control is assayed with target values and is suitable for use on various immunoassay analysers. The Pre-eclampsia Control is for use by trained laboratory professionals and can be used in determining the precision of testing systems and in identifying sources of variation.

Features & Benefits

  • – Liquid frozen for user convenience
  • – Human based serum ensuring a commutable sample matrix
  • – 30 days open vial stability when stored at 2ºC to 8ºC keeping waste and costs to a minimum
  • – True third party control providing an unbiased assessment of performance
  • – Assayed target values provided
DescriptionSizeAnalytesCat NoContact Us
Pre-eclampsia Control Level 1 3 x 2 x 2 ml2PE10527
Pre-eclampsia Control Level 23 x 2 x 2 ml2PE10528
Pre-eclampsia Control Level 33 x 2 x 2 ml2PE10529

 

Therapeutic Drug Quality Control

Analytes

  • – sFlt-1
  • – PIGF

Active Vitamin B12 Quality Control

The Randox Acusera Active Vitamin B12 Control is designed to deliver a cost-effective, high quality solution for use in the quantitative determination of Active Vitamin B12 in human serum and plasma.

The human material based Active B12 Controls are assayed with target values provided and are suitable for use on various analysers.

Features & Benefits

  • Liquid frozen for user convenience
  • Human based serum ensuring a commutable sample matrix
  • True Third Party control providing unbiased assessment of performance
  • An impressive open vial stability of 30 days at 2° to 8°C helping to keep waste to a minimum
DescriptionSizeAnalytesCat No
Active Vitamin B12 Control Level 13 x 2 ml1VB10524
Active Vitamin B12 Control Level 23 x 2 ml1VB10525
Therapeutic Drug Quality Control

Analytes

  • Active Vitamin B12 (Holotranscobalamin/HoloTC)

Bone Markers (Serum) Control

The Lyophilised Serum Bone Marker Control is intended for use with in vitro diagnostic assays for the quantitative determination of Procollagen Type 1 N-Terminal Propeptide (P1NP), N-MID Osteocalcin (OC) and Bone Alkaline Phosphatase (B-ALP) in serum samples.

This Lyophilised Serum Bone Marker Control is assayed with target values and is suitable for use on automated analysers.

Features & Benefits

  • – Lyophilised for enhanced stability
  • – True third party control providing an unbiased assessment of performance
  • – Three clinically relevant levels available
  • – Human based serum providing a matrix similar to the patient sample
  • – 1 year shelf life from date of manufacture allowing for long term QC monitoring and a decrease in new lot validation studies
  • – 14- day reconstituted open vial stability applies for PINP and B-ALP helping to keep waste to a minimum, 1-day reconstituted stability for N-MID Osteocalcin
DescriptionSizeAnalytesCat NoContact Us
Bone Makers (Serum) Control Level 1 6 x 2ml3SBM10574
Bone Makers (Serum) Control Level 26 x 2ml3SBM10587
Bone Makers (Serum) Control Level 36 x 2ml3SBM10588

 

Therapeutic Drug Quality Control

Analytes

  • – PINP
  • – N-MID Osteocalcin
  • – Bone-ALP

*No claims are made regarding values and stability.


Xanthochromia Quality Control

The Randox Acusera Xanthochromia Control is designed to deliver a cost-effective, true third party solution for use in monitoring the performance of Bilirubin and Oxyhaemoglobin in Cerebrospinal Fluid (CSF) using a spectrophotometer.

Aqueous based with components of human origin, the Xanthochromia Controls are unassayed and are suitable for use with various UV spectrophotometers.

Supplied in a liquid frozen format, this control should be treated in the same manner as a patient sample.

Features & Benefits

  • Liquid frozen format for convenience and reduced handling errors
  • Human Based Material
  • True Third Party control providing unbiased assessment of performance
  • An Open Vial stability of 2 days at 2° to 8°C. Stable for 11 weeks when stored unopened at -18° to -24°C helping to keep waste to a minimum.
DescriptionSizeAnalytesCat NoContact Us
Xanthochromia Positive Control6 x 4 ml2XN10505
Xanthochromia Negative Control6 x 4 ml2XN10502
Therapeutic Drug Quality Control

Analytes

  • Billirubin
  • Oxyhaemoglobin

*No claims are made regarding values and stability.


Product Focus: Latest RIQAS Programmes

RIQAS is the largest international External Quality Assessment (EQA)/ Proficiency Testing (PT) scheme, with over 45,000 participants across 32 comprehensive programme options. Providing access to large, international peer groups you can be confident in the statistical validity of the results obtained.

In March 2016, we added eight new RIQAS EQA programmes to our already extensive portfolio. The new programmes included; CSF, Sweat Testing, Immunosuppressant drugs, Trace Elements in Serum, Trace Elements in Urine, Trace Elements in Blood, Anti-TSH Receptor (TRAb) and Cyfra 21-1.

Like all programmes the latest additions are designed to cover the full clinical decision range, reassuring clinicians and patients that the results released are accurate and reliable. The added benefit of monthly reporting supports the rapid identification of errors, this combined with a report turnaround of 24-72 hours from the submission deadline allows faster implementation of any necessary corrective actions, reducing the need for expensive and time consuming patient sample retests.

With Cycle 2 of the new programmes just around the corner we thought we would take this opportunity to explore what each programme has to offer.

Week 1- Trace Elements in Serum, Trace Elements in Urine, Trace Elements in Blood

RIQAS provide three trace element programmes designed for use in clinical and toxicology laboratories specialising in the testing of trace metals, heavy metals and minerals. Options are available for blood, serum and urine ensuring a matrix similar to that of the patient sample. Each programme will help ensure the accuracy of test results in patients who have experienced accidental or occupational exposure to such toxic metals

Main Features and Benefits;

  • Lyophilised samples
  • Monthly reporting
  • Testing covers the full range of clinically relevant decision levels
  • Submit results and view reports online via RIQAS.net
  • 12 month subscription

Week 2- CYFRA 21-1 & Anti-TSH Receptor 

The RIQAS CYFRA 21-1 EQA programme is designed to cover the analysis of the tumour marker CYFRA 21-1 in clinical laboratories when monitoring the response to treatment of cancers such as non-small cell lung carcinoma, cervical, breast and bladder cancer.

Main Features and Benefits;

  • Lyophilised samples
  • Monthly reporting
  • Testing covers the full range of clinically relevant decision levels
  • Submit results and view reports online via RIQAS.net
  • 12 month subscription

Our dedicated Anti-TSH Receptor EQA programme is designed to supplement our general immunoassay programme by including the thyroid hormone Anti-TSH Receptor also known as TRAb.

Main Features and Benefits;

  • Lyophilised samples
  • Monthly reporting
  • Testing covers the full range of clinically relevant decision levels
  • Submit results and view reports online via RIQAS.net
  • 12 month subscription

Week 3 – CSF & Sweat Testing

The RIQAS Cerebrospinal Fluid EQA programme has been designed to monitor the performance of several analytes in CSF.

Main Features and Benefits;

  • Liquid ready-to-use samples
  • Monthly reporting
  • Testing covers the full range of clinically relevant decision levels
  • Submit results and view reports online via RIQAS.net
  • 12 month subscription

The RIQAS Sweat Testing EQA programme has been designed to cover the analysis of Sweat Testing in clinical laboratories measuring the concentration of Chloride, Sodium and Conductivity in sweat, used in the testing of Cystic Fibrosis (CF).

Main Features and Benefits;

  • Liquid ready-to-use samples
  • Monthly reporting
  • Testing covers the full range of clinically relevant decision levels
  • Submit results and view reports online via RIQAS.net
  • 12 month subscription

Week 4 – RIQAS Immunosuppressant EQA programme

The RIQAS Immunosuppressant Drug EQA programme has been designed to cover the analysis of Cyclosporin, Everolimus, Sirolimus and Tacrolimus in clinical laboratories.

Main Features and Benefits;

  • Lyophilised samples
  • Monthly reporting
  • Testing covers the full range of clinically relevant decision levels
  • Submit results and view reports online via RIQAS.net
  • 12 month subscription

Liquid CSF Quality Control

Therapeutic Drug Quality Control

Providing a true third party solution for the measurement of Cerebrospinal Fluid (CSF), the Acusera Liquid CSF Control is designed to deliver an unbiased, independent assessment of analytical performance for 14 analytes, helping to ensure the results clinical laboratories release are accurate and reliable.

With an extended open vial stability of 30 days at 2oC – 8oC, the Acusera Liquid CSF Control will reduce waste, while remaining easy and convenient to use.

Features & Benefits

  • Liquid ready-to-use samples requiring no preparation
  • Human based material
  • True third party control providing unbiased performance assessment
  • Assayed target values available
  • Shelf life of 2 years from the date of manufacture
  • Open vial stability of 30 days for all analytes when stored at 2oC to 8oC
DescriptionSizeAnalytesCat No
Liquid CSF Control Level 110 x 3ml14CF10138
Liquid CSF Control Level 210 x 3ml14CF10139

Analytes

  • Albumin
  • Albumin (electrophoresis)*
  • Alpha – 1- globulin (electrophoresis)*
  • Alpha – 2- globulin (electrophoresis)*
  • Beta- globulin (electrophoresis)*
  • Chloride
  • Gamma – globulin (electrophoresis)*
  • Glucose
  • hsIgA*
  • hsIgG
  • hsIgM*
  • Lactate
  • Protein (Total)
  • Sodium

*No claims are made regarding values and stability.


CSF Quality Control

Therapeutic Drug Quality Control

The Randox Acusera cerebrospinal fluid quality control is designed for use in the routine monitoring of both accuracy and precision on a wide range of instruments. Assayed method specific target values and ranges are provided for 11 parameters including percentage total protein quoted for electrophoresis regions at Albumin, Alpha-1-Globulin, Alpha-2-Globulin, Beta Globulin and Gamma Globulin.

Features & Benefits

  • Lyophilised for enhanced stability
  • Human based material
  • Assayed target values provided for 11 parameters
  • Stable to expiry date at 2°C – 8°C
  • Reconstituted stability of 14 days at 2°C – 8°C
DescriptionSizeAnalytesCat No
CSF Control Level 210 x 3ml11CF1500
CSF Control Level 310 x 3ml11CF1501

Analytes

  • Albumin (electrophoresis)*
  • Alpha – 1- globulin (electrophoresis)*
  • Alpha – 2- globulin (electrophoresis)*
  • Beta- globulin (electrophoresis)*
  • Chloride
  • Gamma – globulin (electrophoresis)*
  • Glucose
  • Immunoglobulin G (IgG)
  • Lactate
  • Protein (Total)
  • Sodium

    *No claims are made regarding values or stability


    Request a meeting
    ×
    Make an Enquiry - RX series
    ×
    Make an Enquiry - Reagents
    ×
    Kit Insert Request - Reagents
    • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
    ×
    Kit Insert Request - Reagents
    • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
    ×
    Make an Enquiry - Reagents
    ×
    Make an Enquiry - Quality Control
    ×
    Make an Enquiry - RIQAS
    ×
    Make an Enquiry - RIQAS